Advertisement

Molecular determination, serotyping, antibiotic profile and virulence factors of group B Streptococcus isolated from invasive patients at Arabcare Hospital Laboratory, Palestine

Published:December 25, 2021DOI:https://doi.org/10.1016/j.ajic.2021.12.006

      Highlights

      • Streptococcus agalactiae research studies are lacking in Palestine.
      • We investigate the serotypes, virulent genes, and antibiotic profile of the invasive group B Streptococcus strains.
      • Serotype III most is predominant among local isolates.
      • Resistant group B Streptococcus strains are common in Palestine.
      • Evidence-based infection prevention and antibiotic stewardship efforts are needed.

      Abstract

      Background

      Streptococcus agalactiae (group B Streptococcus) is beta-hemolytic, catalase negative, gram-positive cocci, recognized as main bacterial pathogen causing infections in newborns, infants, adults, and elderly people around the world. The aim of this study is to investigate group B Streptococcus samples recovered from invasive patients and determine serotype, virulent genes, and antibiotic-resistant profile of Streptococcus agalactiae in Palestine.

      Methods

      A total of 95 group B Streptococcus strains were isolated from neonates, infants, pregnant and non-pregnant women and males at Arabcare Hospital Laboratory, Palestine, between the period of June 2018 and September 2020. Species identification was carried out through cultivation and conventional biochemical tests. A conventional Polymerase Chain Reaction (cPCR) was used to determine the 5 serotypes and virulent genes of the Streptococcus agalactiae strains. The antibiotic resistance test of group B Streptococcus was evaluated using Kirby-Bauer disk susceptibility. Sequencing and BLAST analysis were used to determine the relationship of the isolates in this study to worldwide isolates.

      Results

      Serotype III (35%) was the major group B Streptococcus strains serotype causing invasive infections in neonates, infants, pregnant and nonpregnant women, and males, followed by serotypes V (19%), Ia, and II (15%), Ib (6%), respectively. All our isolates encoding for surface protein virulent factors, including a highly virulent gene (HvgA) were mostly found in strains isolated from pregnant women (12%). These group B Streptococcus strains exhibited a high rate of resistance to clindamycin (26%). The overall percentage of levofloxacin resistance was 11%, while vancomycin and ampicillin showed higher resistance, at 14.7 and 16% respectively. In addition, the phylogenetic relationship dendrogram illustrates that Streptococcus agalactiae isolated from an invasive patient (newborn) in Palestine was similar to strains found in China and Japan.

      Conclusions

      The outcomes of this study demonstrate that resistant group B Streptococcus strains are common in Palestine, therefore, evidence-based infection prevention and antibiotic stewardship efforts are necessary.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Raabe V
        • Shane A
        Streptococcus group B (Streptococcus agalactia).
        Microbiol Spectr. 2019; 7
        • Li C
        • Nanayakkara D.
        • Sapugahawatte D
        • et al.
        Multidrug-resistant Streptococcus agalactiae strains found in human and fish with high penicillin and cefotaxime non-susceptibilities.
        Microorganisms. 2020; 8: 1055
        • Mukhopadhyay S
        • Dukhovny D
        • Mao W
        • Eichenwald E
        • Puopolo K
        Perinatal GBS prevention guideline and resource utilization.
        Pediatrics. 2010; 133: 196-203
        • Kwatra G
        • Cunnington M
        • Merrall E
        • et al.
        Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis.
        Lancet Infect Dis. 2016; 16: 1076-1084
        • Le Doare K
        • O’Driscoll M
        • Turner K
        • Seedat F
        • Russell NJ
        • Seale C
        Intrapartum antibiotic chemoprophylaxis policies for the prevention of group B streptococcal disease worldwide: systematic review.
        Clin Infect Dis. 2017; 65: S143-S151
        • Medugu N
        • Iregbu K
        • Parker R
        • et al.
        Group B streptococcal colonization and transmission dynamics in pregnant women and their newborns in Nigeria: implications for prevention strategies.
        Clin Microbiol Infect. 2017; 23 (673.e9-673.e16)
        • Shabayek S
        • Spellerberg B.
        Group B streptococcal colonization, molecular characteristics, and epidemiology.
        Front Microbiol. 2018; 9: 437
        • Law MR
        • Palomaki G
        • Alfirevic Z
        • et al.
        The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society.
        J Med Screen;. 2005; 12: 60-68
        • Martins E
        • Pedroso-Roussado C
        • Melo-Cristino J
        • Ramirez M
        • The Portuguese Group for the Study of Streptococcal Infections
        Streptococcus agalactiae causing neonatal infections in Portugal (2005–2015): diversification and emergence of a CC17/PI-2b multidrug resistant sublineage.
        Front Microbiol. 2017; 8: 499
        • Shet A.
        • Ferrieri P.
        Neonatal & maternal group B streptococcal infections: a comprehensive review.
        Indian J Med Res. 2004; 120: 141
        • Verani J.R.
        • McGee L.
        • Schrag S.J.
        • Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC)
        Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010.
        MMWR Recomm. Rep. 2010; 59: 1-36
        • Berardi A.
        • Rossi C
        • Lugli L
        • et al.
        • GBS Prevention Working Group, Emilia-Romagna
        Group B Streptococcus late-onset disease: 2003-2010.
        Pediatrics. 2013; 131: e361-e368
        • Melin P.
        • Efstratiou A.
        Group B streptococcal epidemiology and vaccine needs in developed countries.
        Vaccine. 2013; 31: D3-D42
        • Zimmermann P.
        • Gwee A.
        • Curtis N
        The controversial role of breast milk in GBS late-onset disease.
        J Infect. 2017; 74: S34-S40
        • Bianchi-Jassir F
        • Paul P
        • To KN
        • et al.
        Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates.
        Vaccine. 2020; 38: 6682-6694
        • Lindahl G
        • Stålhammar-Carlemalm M
        • Areschoug T.
        Surface proteins of streptococcus agalactiae and related proteins in other bacterial pathogens.
        Clin Microbiol Rev. 2005; 18: 102-127
        • Cutting A
        • Del Rosario Y
        • Mu R
        • et al.
        The role of autophagy during group B Streptococcus infection of blood-brain barrier endothelium.
        J Biol Chem. 2014; 289: 35711-35723
        • Furfaro L
        • Chang B
        • Payne M
        Perinatal Streptococcus agalactiae epidemiology and surveillance targets.
        Clin Microbiol Rev. 2018; : 31
        • Lópeza Y
        • Parraa E
        • Cepasa V
        • et al.
        Serotype, virulence profile, antimicrobial resistance and macrolide –resistance determinants in Streptococcus agalactiae isolates in pregnant women and neonates in Catalonia, Spain.
        Enferm Infecc Microbiol Clin. 2020; 36: 472-477
        • CLSI
        Performance Standards for Antimicrobial Susceptibility Testing.
        in: 27th Informational Supplement; M100-S27; Clinical and Laboratory Standards Institute, Wayne, PA, USA2019
        • Furfaro L
        • Chang B
        • Kehler C
        • Payne M
        Genomic characterization of perinatal Western Australian Streptococcus agalactiae isolates.
        PLoS ONE. 2019; 14e0223256
        • Furfaro L
        • Chang BJ
        • Payne MS
        A novel one-step real-time multiplex PCR assay to detect Streptococcus agalactiae presence and serotypes Ia, Ib, and III.
        Diagn Microbio Infect Dis. 2017; 89: 7-12
        • Otaguiri E
        • Morguette A
        • Tavares E
        • Yamada-Ogatta S
        • Santos P
        • Morey A
        Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Paraná, Brazil: Capsular types, genotyping, antimicrobial susceptibility and virulence determinants.
        BMC Microbiol. 2013; 13: 297
        • Jones N.
        • Bohnsack J.
        • Takahashi S.
        • et al.
        Multilocus Sequence Typing System for Group B Streptococcus.
        J Clin Microbiol. 2003; 41: 2530-2536
        • Zhao Z
        • Kong F
        • Martinez G
        • Zeng X
        • Gottschalk M
        • Gilbert GL
        Molecular serotype identification of Streptococcus agalactiae of bovine origin by multiplex PCR-based reverse line blot (mPCR/RLB) hybridization assay.
        FEMS Microbiol Lett. 2006; 263: 236-239
        • Duarte R
        • Bellei B
        • Miranda O
        • Brito M
        • Teixeira L
        Distribution of antimicrobial resistance and virulence-related genes among Brazilian Group B streptococci recovered from bovine and human sources.
        Antimicrob Agents Chemother. 2005; 49: 97-103
        • Lamy M.C.
        • Dramsi S.
        • Billoët A.
        • et al.
        Rapid detection of the “highly virulent” group B Streptococcus ST-17 clone.
        Microbes Infect. 2006; 8: 1714-1722
        • Muñoz P
        • Llancaqueo A
        • Rodríguez-Créixems M
        • Peláez T
        • Martin L
        • Bouza E
        Group B streptococcus bacteremia in nonpregnant adults.
        Arch Intern Med. 1997; 157: 213-216
        • Madrid L
        • Seale C
        • Kohli-Lynch M
        • Edmond M
        • Lawn E
        Infant Group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses.
        Clin Infect Dis. 2017; 65: S160-S172
        • Wu J
        • Li L
        • Wu W
        • et al.
        Phenotypic and genetic differences among group B Streptococcus recovered from neonates and pregnant women in Shenzhen, China: 8-year study.
        BMC Microbiology. 2019; 19: 185
        • Botelho A
        • Oliveira J
        • Damasco A
        • et al.
        Streptococcus agalactiae carriage among pregnant women living in Rio de Janeiro, Brazil, over a period of eight years.
        PLoS ONE. 2020; 13e0196925
        • Fanrong K
        • Gidding H
        • Berner R
        • Gilbert G
        Streptococcus agalactiae Cb protein gene (bac) sequence types, based on the repeated region of the cell-wall-spanning domain: relationship to virulence and a proposed standardized nomenclature.
        J Med Microbiol. 2006; 55: 829-837
        • Genovese C
        • D’Angeli F
        • Di Salvatore V
        • Tempera G
        • Nicolosi D
        Streptococcus agalactiae in pregnant women: serotype and antimicrobial susceptibility patterns over five years in Eastern Sicily (Italy).
        Eur J Clin Microbiol Infecti Dis. 2020; 39: 2387-2396
        • Campisi E
        • Rosini R
        • Ji W
        • et al.
        Genomic analysis reveals multi-drug resistance clusters in Group B Streptococcus CC17 hypervirulent isolates causing neonatal invasive disease in Southern Mainland China.
        Front Microbiol. 2016; 7: 1265
        • Tazi A
        • Disson O
        • Bellais S
        • et al.
        The surface protein HvgA mediates group B Streptococcus hypervirulence and meningeal tropism in neonates.
        J Exp Med. 2010; 207: 2313-2322
        • Teatero S
        • McGeer A
        • Low E
        • et al.
        Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada.
        J Clin Microbiol. 2014; 52: 1441-1447
        • Bobadilla F.
        • Novosak M.
        • Cortese I.
        • Delgado O
        • Laczeski M.
        Prevalence, serotypes and virulence genes of Streptococcus agalactiae isolated from pregnant women with 35–37 weeks of gestation.
        BMC Infect Dis. 2021; 21: 73
        • Cheng Z
        • Qu P
        • Ke P
        • et al.
        Antibiotic Resistance and Molecular Epidemiological Characteristics of Streptococcus agalactiae Isolated from Pregnant Women in Guangzhou, South China.
        Can J Infect Dis Med Microbiol. 2020; 2020 (Article ID 1368942, 11 pages)
        • Gizachew M
        • Tiruneh M
        • Moges F
        • Tessema B
        Serotype distribution, antimicrobial resistance, and molecular characterization of invasive group B Streptococcus isolates recovered from Chinese neonates.
        BMC Infect Dis. 2020; 20: 35
        • Wang P.
        • Tong J.J.
        • Ma X.H.
        • et al.
        Serotypes, antibiotic susceptibilities, and multi-locus sequence type profiles of Streptococcus agalactiae isolates circulating in Beijing. China.
        LoS ONE. 2015; 10e0120035
        • Gherardi G
        • Imperi M
        • Baldassarri L
        • et al.
        Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy.
        J Clin Microbiol. 2007; 45: 2909-2916
        • Hannoun A
        • Shehab M
        • Khairallah M-T
        • et al.
        Correlation between group B streptococcal genotypes, their antimicrobial resistance profiles, and virulence genes among pregnant women in Lebanon.
        Int J Microbiol. 2009; : 1-6
        • Tazi A
        • Morand C
        • Réglier-Poupet H
        • et al.
        Invasive group B streptococcal infections in adults, France (2007–2010).
        Clin Microbiol Infect. 2011; 17: 1587-1589
        • Wang P.
        • Ma Z.
        • Tong J.
        • et al.
        Serotype distribution, antimicrobial resistance, and molecular characterization of invasive group B Streptococcus isolates recovered from Chinese neonates.
        Int J Infect Dis. 2015; 37: 115-118
        • Zhang L
        • Ma L
        • Zhu L
        • et al.
        Molecular characterization of pathogenic group B streptococcus from a tertiary hospital in Shanxi, China: High incidence of sequence type 10 strains in infants/pregnant women.
        J Microbiol Immunol Infect. 2020; 54: 1094-1100
        • Hu Y.
        • Kan Y.
        • Zhang Z.
        • et al.
        New mutations of penicillin-binding proteins in Streptococcus agalactiae isolates from cattle with decreased susceptibility to penicillin.
        Microb Drug Resist. 2018; 24: 1236-1241